Bangladesh · Delayed Price · Currency is BDT Navana Pharmaceuticals Statistics
Total Valuation
DSE:NAVANAPHAR has a market cap or net worth of BDT 6.18 billion. The enterprise value is 10.07 billion.
| Market Cap | 6.18B |
| Enterprise Value | 10.07B |
Important Dates
The last earnings date was Wednesday, January 28, 2026.
| Earnings Date | Jan 28, 2026 |
| Ex-Dividend Date | Nov 20, 2025 |
Share Statistics
DSE:NAVANAPHAR has 107.42 million shares outstanding. The number of shares has increased by 0.45% in one year.
| Current Share Class | 107.42M |
| Shares Outstanding | 107.42M |
| Shares Change (YoY) | +0.45% |
| Shares Change (QoQ) | +0.03% |
| Owned by Insiders (%) | 23.53% |
| Owned by Institutions (%) | n/a |
| Float | 39.44M |
Valuation Ratios
The trailing PE ratio is 10.18.
| PE Ratio | 10.18 |
| Forward PE | n/a |
| PS Ratio | 0.61 |
| PB Ratio | 1.19 |
| P/TBV Ratio | 1.19 |
| P/FCF Ratio | 2.98 |
| P/OCF Ratio | 2.63 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 5.47, with an EV/FCF ratio of 4.86.
| EV / Earnings | 16.53 |
| EV / Sales | 1.00 |
| EV / EBITDA | 5.47 |
| EV / EBIT | 6.63 |
| EV / FCF | 4.86 |
Financial Position
The company has a current ratio of 0.93, with a Debt / Equity ratio of 0.80.
| Current Ratio | 0.93 |
| Quick Ratio | 0.26 |
| Debt / Equity | 0.80 |
| Debt / EBITDA | 2.25 |
| Debt / FCF | 2.00 |
| Interest Coverage | 2.38 |
Financial Efficiency
Return on equity (ROE) is 12.27% and return on invested capital (ROIC) is 12.36%.
| Return on Equity (ROE) | 12.27% |
| Return on Assets (ROA) | 8.29% |
| Return on Invested Capital (ROIC) | 12.36% |
| Return on Capital Employed (ROCE) | 26.42% |
| Weighted Average Cost of Capital (WACC) | 7.39% |
| Revenue Per Employee | 2.10M |
| Profits Per Employee | 126,936 |
| Employee Count | 4,798 |
| Asset Turnover | 0.88 |
| Inventory Turnover | 2.45 |
Taxes
In the past 12 months, DSE:NAVANAPHAR has paid 210.49 million in taxes.
| Income Tax | 210.49M |
| Effective Tax Rate | 25.68% |
Stock Price Statistics
The stock price has decreased by -1.36% in the last 52 weeks. The beta is 0.08, so DSE:NAVANAPHAR's price volatility has been lower than the market average.
| Beta (5Y) | 0.08 |
| 52-Week Price Change | -1.36% |
| 50-Day Moving Average | 58.37 |
| 200-Day Moving Average | 54.92 |
| Relative Strength Index (RSI) | 48.58 |
| Average Volume (20 Days) | 303,790 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, DSE:NAVANAPHAR had revenue of BDT 10.07 billion and earned 609.04 million in profits. Earnings per share was 5.65.
| Revenue | 10.07B |
| Gross Profit | 4.36B |
| Operating Income | 1.52B |
| Pretax Income | 819.53M |
| Net Income | 609.04M |
| EBITDA | 1.80B |
| EBIT | 1.52B |
| Earnings Per Share (EPS) | 5.65 |
Balance Sheet
The company has 208.61 million in cash and 4.14 billion in debt, with a net cash position of -3.89 billion or -36.25 per share.
| Cash & Cash Equivalents | 208.61M |
| Total Debt | 4.14B |
| Net Cash | -3.89B |
| Net Cash Per Share | -36.25 |
| Equity (Book Value) | 5.19B |
| Book Value Per Share | 48.32 |
| Working Capital | -426.95M |
Cash Flow
In the last 12 months, operating cash flow was 2.35 billion and capital expenditures -276.03 million, giving a free cash flow of 2.07 billion.
| Operating Cash Flow | 2.35B |
| Capital Expenditures | -276.03M |
| Depreciation & Amortization | 285.64M |
| Net Borrowing | -1.03B |
| Free Cash Flow | 2.07B |
| FCF Per Share | 19.28 |
Margins
Gross margin is 43.25%, with operating and profit margins of 15.07% and 6.05%.
| Gross Margin | 43.25% |
| Operating Margin | 15.07% |
| Pretax Margin | 8.14% |
| Profit Margin | 6.05% |
| EBITDA Margin | 17.91% |
| EBIT Margin | 15.07% |
| FCF Margin | 20.56% |
Dividends & Yields
This stock pays an annual dividend of 1.40, which amounts to a dividend yield of 2.43%.
| Dividend Per Share | 1.40 |
| Dividend Yield | 2.43% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 7.19% |
| Buyback Yield | -0.45% |
| Shareholder Yield | 1.96% |
| Earnings Yield | 9.86% |
| FCF Yield | 33.52% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
DSE:NAVANAPHAR has an Altman Z-Score of 1.97 and a Piotroski F-Score of 7. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.97 |
| Piotroski F-Score | 7 |